Company Filing History:
Years Active: 1998-2000
Title: John M Kyriakis: Innovator in Molecular Biology
Introduction
John M Kyriakis is a notable inventor based in Dedham, MA (US). He has made significant contributions to the field of molecular biology, particularly in the study of stress response mechanisms. With a total of 2 patents, his work has implications for understanding cellular responses to oxidative stress.
Latest Patents
Kyriakis's latest patents include groundbreaking research on nucleic acid molecules encoding Ste20 oxidant stress response kinase-1. One of his patents details a SOK polypeptide and an isolated DNA sequence that encodes this polypeptide. The patent outlines a method for determining whether a candidate compound modulates SOK-1 activity or expression. This method involves providing two recombinant cells expressing a SOK gene, introducing a candidate compound into one cell, and measuring SOK function in both cells. The results help determine if the candidate compound affects SOK expression or activity.
Career Highlights
John M Kyriakis is affiliated with The General Hospital Corporation, where he continues to advance research in his field. His work has been instrumental in developing methods that could lead to new therapeutic strategies for diseases related to oxidative stress.
Collaborations
Kyriakis has collaborated with notable colleagues such as Thomas Force and Celia M Pombo. These partnerships have enhanced the scope and impact of his research.
Conclusion
John M Kyriakis is a prominent figure in molecular biology, with a focus on stress response mechanisms. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and potential therapeutic applications.